141 results on '"Li, Tianxia"'
Search Results
2. WRN helicase is a synthetic lethal target in microsatellite unstable cancers
3. Supplement Methods from RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade
4. Figure S4 from RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade
5. Supplementary Table 3 from RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade
6. Supplementary Table 1, 2 and 4 from RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade
7. Data from RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade
8. Figure S6 and S7 from RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade
9. Data from Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
10. Supplementary Figures 1-10 from Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
11. Supplementary Table S3 from Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer
12. Data from Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer
13. Supplementary Figures S1-S11 from Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer
14. P53-induced GAP-43 Upregulation in Primary Cortical Neurons of Rats
15. The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration
16. Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
17. Developing SHP2-based combination therapy for KRAS-amplified cancer
18. Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer
19. Effective Strategies to Promote the Cultivation of Public Legal Consciousness from the Perspective of Social Psychology
20. Ellagic acid-induced thrombotic focal cerebral ischemic model in rats
21. Abstract 6377: Developing combination therapy with SHP2 inhibition for CIN-type gastroesophageal adenocarcinoma with KRAS amplification
22. Hypogyrification in Generalized Anxiety Disorder and Associated with Insomnia Symptoms
23. Sa1235 MODELING CHEMOTHERAPY RESISTANCE FACTORS USING PATIENT DERIVED ESOPHAGEAL ADENOCARCINOMA ORGANOIDS
24. 225 MODELING THE TUMOR MICROENVIRONMENT OF EARLY AND LATE ONSET COLORECTAL CANCER USING PATIENT-DERIVED ORGANOIDS
25. A Longitudinal Empirical Study on Low Carbon Logistics Efficiency in Shaanxi Province
26. Research on the development level of logistics in Beibu gulf (Guangxi) economic region based on fuzzy substance element
27. Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinsonʼs disease cell and mouse models
28. A LRRK2 GTP Binding Inhibitor, 68, Reduces LPS-Induced Signaling Events and TNF-α Release in Human Lymphoblasts
29. Case Report: A Case Report and Literature Review of 3p Deletion Syndrome
30. Synphilin-1 Interacts with AMPK and Increases AMPK Phosphorylation
31. GTP‐binding inhibitors increase LRRK2‐linked ubiquitination and Lewy body‐like inclusions
32. AMPK signaling mediates synphilin-1-induced hyperphagia and obesity in drosophila
33. Protective Effect of Protopine on the Focal Cerebral Ischaemic Injury in Rats
34. Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
35. RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade
36. Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
37. 68 and FX2149 Attenuate Mutant LRRK2-R1441C-Induced Neural Transport Impairment
38. Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1
39. Synphilin-1 attenuates mutant LRRK2-induced neurodegeneration in Parkinson's disease models
40. CCK Response Deficiency in Synphilin-1 Transgenic Mice
41. The Drosophilahep pathway mediates Lrrk2-induced neurodegeneration.
42. Models for LRRK2-Linked Parkinsonism
43. A Novel GTP-Binding Inhibitor, FX2149, Attenuates LRRK2 Toxicity in Parkinson’s Disease Models
44. LDN-73794 Attenuated LRRK2-Induced Degeneration in a <i>Drosophila</i> Parkinson’s Disease Model
45. Synphilin-1 Binds ATP and Regulates Intracellular Energy Status
46. From fat fruit fly to human obesity
47. Behavioral Characterization of the Hyperphagia Synphilin-1 Overexpressing Mice
48. Curcumin protects against rotenone-induced neurotoxicity in cell and drosophila models of Parkinson’s disease
49. LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: Suppression by curcumin
50. Preproendothelin-1 expression is negatively regulated by IFNγ during hepatic stellate cell activation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.